nelfinavir has been researched along with Dunnigan Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auclair, M; Béréziat, V; Bodemer, C; Capeau, J; Caron, M; Donadille, B; Guerci, B; Lascols, O; Laville, M; Narbonne, H; Vigouroux, C | 1 |
1 other study(ies) available for nelfinavir and Dunnigan Syndrome
Article | Year |
---|---|
Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence.
Topics: Adult; Biopsy; Cell Nucleus Shape; Cells, Cultured; Cellular Senescence; Child; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Female; Fibroblasts; HIV Protease Inhibitors; Humans; Indinavir; Lamin Type A; Lipodystrophy, Familial Partial; Middle Aged; Mitochondria; Mutation; Nelfinavir; Nuclear Proteins; Oxidative Stress; Protein Precursors; Reactive Oxygen Species | 2007 |